Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV001181027 | SCV001346081 | uncertain significance | Familial hypercholesterolemia | 2023-08-04 | criteria provided, single submitter | clinical testing | This variant causes a T to G nucleotide substitution at the -14 position of intron 1 of the PCSK9 gene. To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with cardiovascular disorders in the literature. This variant has been identified in 6/249586 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. |
All of Us Research Program, |
RCV004006713 | SCV004826578 | uncertain significance | Hypercholesterolemia, autosomal dominant, 3 | 2023-08-15 | criteria provided, single submitter | clinical testing | This variant causes a T to G nucleotide substitution at the -14 position of intron 1 of the PCSK9 gene. To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with cardiovascular disorders in the literature. This variant has been identified in 6/249586 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. |
Labcorp Genetics |
RCV004006713 | SCV005821691 | likely benign | Hypercholesterolemia, autosomal dominant, 3 | 2024-12-04 | criteria provided, single submitter | clinical testing |